The Disappointing Reality of Crowdfunding Cancer Care
If crowdfunding doesn’t work, here’s how oncologists can help patients with financial toxicity.
Gynecologic Cancers
Some Targeted Therapies May Miss the Mark
Ten different drugs continued to kill cancer cells even when their target proteins were removed.
Feasibility of Nurse-Led Consultations to Manage ChemoRadiotherapy for Gynecologic Cancer Explored in Pilot Program
A pilot program investigated the value of systematic nurse-led consultations in lieu of physician-led consultations for both patients with gynecologic cancers and the nurse specialist consultants.
Geriatric Vulnerability Score Validated for Use in Managing Care of Older Patients With Ovarian Cancer
Results of an analysis that validated the use of the GVS to determine vulnerability in older patients with ovarian cancer.
The Effects of Cancer on Sexuality for Adolescents and Young Adults With Reproductive Cancers
A German study evaluated how site and type of cancer affects sexuality in adolescents and young adults.
Germline BRCA2 Mutations Linked to Pediatric Lymphomas
Survivors of NHL should be offered genetic counseling.
Best Practices for Handling BCG Waste
What is the proper procedure for handling bacillus Calmette-Guerin (BCG) waste? Does the room need to be closed off after instilling the drug into the bladder?
Pain Associated With Quality of Life and Survival for Patients With Recurrent Ovarian Cancer
Researchers sought to analyze how pain management affects quality of life and overall survival for patients with recurrent ovarian cancer.
Biosimilars Mvasi, Kanjinti Now Available in the US
Biosimilars Mvasi and Kanjinti are now available in the United States.
Zejula Gets Priority Review for Late Stage Ovarian Cancer Indication
The sNDA is supported by data from the multicenter phase 2 QUADRA trial that evaluated the safety and activity of Zejula in 463 patients.
